3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Brain Neoplasms
5
Radiation Injuries
1
Oligodendroglioma
1
Neurotoxicity Syndromes
1
Neurofibromatosis 1
1
Multiple Myeloma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Glioma
1
Glioblastoma
1
Fatigue
1
Cytokine Release Syndrome
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Breast Neoplasms
1
Astrocytoma
1
Interventions
siltuximab
1
otelixizumab
1
fludarabine
1
axicabtagene ciloleucel
1
Neuropsychological Tests
1
Magnetic Resonance Spectroscopy
1
Leukapheresis
1
Interleukin 1 Receptor Antagonist Protein
1
Gelsolin
1
Cyclophosphamide
1
Contrast Media
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Cytokine Release Syndrome
×
Neuropsychological Tests
×
Clear all
NCT05510596
2024-08-09
MR-ICANS
University Hospital, Montpellier
Phase NA
Completed
25 enrolled